for osteoporosis management
& fracture prevention
The Asia Pacific Consortium on Osteoporosis (APCO) comprises Osteoporosis experts from several countries in Asia Pacific, charged with developing tangible solutions to the substantive challenges involving osteoporosis management and fracture prevention in this most populated and fastest growing region of the world.
Representing multiple medical and surgical specialties, the Consortium has developed a pan-Asia Pacific “Framework” for the introduction and implementation of minimum clinical standards for the screening, diagnosis and management of osteoporosis targeting a broad range of high-risk groups.
0Osteoporosis experts from 23 countries and regions
Representing Osteoporosis experts from 23 countries and regions
APCO (Asia Pacific Consortium on Osteoporosis) is charged with developing tangible solutions to the substantive challenges involving osteoporosis management and fracture prevention.
A common disease characterised by porous brittle bones, low bone density and quality, and structural deterioration
Osteoporosis is defined as having a bone mineral density (BMD) 2.5 standard deviations below the average value of a young healthy person, leading to enhanced bone fragility, and increased fracture risk. More than 200 million people worldwide live with osteoporosis.
The APCO Framework
A pan-Asia Pacific “Framework” for the implementation of minimum clinical standards across the region
The APCO Framework proposes clear and concise standards of care involving the screening, diagnosis and management of osteoporosis, targeting a broad range of high-risk groups. These standards provide a benchmark for the provision of quality care across Asia Pacific.
To learn more about The APCO Framework, watch our video of APCO Executive Committee Chairperson, Dr Manju Chandran
Watch our 3D animation summarising the APCO Framework
APCO Bone Health QI Tool Kit
Addressing the major public health burden of osteoporosis throughout the Asia Pacific region through the promotion of quality improvement (QI) of osteoporosis care.
Clinical Case Discussion Platform (CCDP)
The APCO Clinical Case Discussion Platform (CCDP) aims to create a platform for doctors across the Asia Pacific to share clinical cases in metabolic bone disease that are challenging and for which they would like to seek management input.